A study, which measured levels of fucosylated HPX found significantly, elevated quantities of its expression in a cohort of 229 serum samples from patients with chronic hepatitis, LC, and HCC [53]; a finding that was previously reported in an earlier publication [54]. Here, HPX is linked to laryngotracheoesophageal cleft.